A Keundjian

693 total citations
29 papers, 542 citations indexed

About

A Keundjian is a scholar working on Public Health, Environmental and Occupational Health, Pharmacology and Epidemiology. According to data from OpenAlex, A Keundjian has authored 29 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Public Health, Environmental and Occupational Health, 7 papers in Pharmacology and 4 papers in Epidemiology. Recurrent topics in A Keundjian's work include Malaria Research and Control (24 papers), Mosquito-borne diseases and control (8 papers) and Drug-Induced Hepatotoxicity and Protection (5 papers). A Keundjian is often cited by papers focused on Malaria Research and Control (24 papers), Mosquito-borne diseases and control (8 papers) and Drug-Induced Hepatotoxicity and Protection (5 papers). A Keundjian collaborates with scholars based in France, Cameroon and Belgium. A Keundjian's co-authors include Pascal Ringwald, Léonardo K. Basco, Rachida Tahar, Albert Same Ekobo, Jacques Le Bras, J. C. Doury, D Baudon, Christian Funck‐Brentano, Philippe Deloron and Agnès Aubouy and has published in prestigious journals such as The Journal of Infectious Diseases, Antimicrobial Agents and Chemotherapy and Clinical Pharmacology & Therapeutics.

In The Last Decade

A Keundjian

28 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Keundjian France 15 437 142 66 62 47 29 542
Francis Hombhanje Japan 14 367 0.8× 121 0.9× 56 0.8× 114 1.8× 56 1.2× 37 513
WM Watkins Kenya 4 407 0.9× 102 0.7× 54 0.8× 101 1.6× 39 0.8× 4 534
K Chalermrut Thailand 15 405 0.9× 125 0.9× 43 0.7× 102 1.6× 57 1.2× 17 481
D Bunnag Thailand 13 398 0.9× 156 1.1× 70 1.1× 62 1.0× 66 1.4× 32 622
A. M. J. Oduola Nigeria 14 548 1.3× 171 1.2× 68 1.0× 94 1.5× 62 1.3× 23 689
TE Taylor United Kingdom 4 481 1.1× 118 0.8× 62 0.9× 115 1.9× 39 0.8× 5 569
J Lebras France 8 490 1.1× 72 0.5× 95 1.4× 77 1.2× 73 1.6× 16 602
Akintunde Sowunmi Nigeria 17 596 1.4× 149 1.0× 100 1.5× 126 2.0× 43 0.9× 51 713
Dorina Bustos Philippines 12 440 1.0× 109 0.8× 70 1.1× 113 1.8× 56 1.2× 18 484
A. A. Adedeji Nigeria 14 471 1.1× 153 1.1× 83 1.3× 72 1.2× 57 1.2× 67 619

Countries citing papers authored by A Keundjian

Since Specialization
Citations

This map shows the geographic impact of A Keundjian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Keundjian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Keundjian more than expected).

Fields of papers citing papers by A Keundjian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Keundjian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Keundjian. The network helps show where A Keundjian may publish in the future.

Co-authorship network of co-authors of A Keundjian

This figure shows the co-authorship network connecting the top 25 collaborators of A Keundjian. A scholar is included among the top collaborators of A Keundjian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Keundjian. A Keundjian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Benakis, A., et al.. (2006). Pharmacokinetics/Pharmacodynamics findings after repeated Administration of ARTESUNATE thermostable suppositories (RECTOCAPS) in Vietnamese patients with uncomplicated malaria. European Journal of Drug Metabolism and Pharmacokinetics. 31(1). 41–45. 8 indexed citations
2.
Davoust, Bernard, et al.. (2005). Validation of chemoprevention of canine monocytic ehrlichiosis with doxycycline. Veterinary Microbiology. 107(3-4). 279–283. 12 indexed citations
3.
Parola, Philippe, et al.. (2005). Chimiosensibilité de Plasmodium falciparum importé des Comores à Marseille en 2002–2003. Médecine et Maladies Infectieuses. 35(10). 489–491. 3 indexed citations
4.
Tifratène, Karim, et al.. (2004). The relationship between body weight and tolerance to mefloquine prophylaxis in non-immune adults: results of a questionnaire-based study. Annals of Tropical Medicine and Parasitology. 98(6). 639–641. 10 indexed citations
5.
Henry, Maud, C. Rogier, Serge-Brice Assi, et al.. (2003). Inland valley rice production systems and malaria infection and disease in the savannah of Côte d'Ivoire. Tropical Medicine & International Health. 8(5). 449–458. 51 indexed citations
6.
Keundjian, A. (2002). [Franco-Vietnamese military cooperation in the field of malaria].. PubMed. 62(2). 202–4. 1 indexed citations
7.
Ralaimazava, Pascal, Rémy Durand, N. Godineau, et al.. (2002). Profile and evolution of the chemosusceptibility of falciparum malaria imported into France in 2000. Eurosurveillance. 7(7). 113–118. 9 indexed citations
8.
Basco, Léonardo K., Mathieu Ndounga, A Keundjian, & Pascal Ringwald. (2002). Molecular epidemiology of malaria in cameroon. IX. Characteristics of recrudescent and persistent Plasmodium falciparum infections after chloroquine or amodiaquine treatment in children.. American Journal of Tropical Medicine and Hygiene. 66(2). 117–123. 21 indexed citations
9.
Pradines, Bruno, et al.. (2002). [Senegal and malaria. True prophylactic failure of mefloquine].. PubMed. 31(24). 1136–1136. 8 indexed citations
10.
Aubouy, Agnès, A Keundjian, Florence Migot‐Nabias, et al.. (2002). Combination of Drug Level Measurement and Parasite Genotyping Data for Improved Assessment of Amodiaquine and Sulfadoxine-Pyrimethamine Efficacies in Treating Plasmodium falciparum Malaria in Gabonese Children. Antimicrobial Agents and Chemotherapy. 47(1). 231–237. 43 indexed citations
11.
Basco, Léonardo K., et al.. (2001). Cardiac effects of amodiaquine and sulfadoxine-pyrimethamine in malaria-infected African patients.. American Journal of Tropical Medicine and Hygiene. 65(6). 711–716. 26 indexed citations
12.
Basco, Léonardo K., Rachida Tahar, A Keundjian, & Pascal Ringwald. (2000). Sequence Variations in the Genes Encoding Dihydropteroate Synthase and Dihydrofolate Reductase and Clinical Response to Sulfadoxine‐Pyrimethamine in Patients with Acute Uncomplicated Falciparum Malaria. The Journal of Infectious Diseases. 182(2). 624–628. 59 indexed citations
13.
14.
15.
Baudon, D, et al.. (1999). Efficacy of daily antimalarial chemoprophylaxis in tropical Africa using either doxycycline or chloroquine-proguanil; a study conducted in 1996 in the French Army. Transactions of the Royal Society of Tropical Medicine and Hygiene. 93(3). 302–303. 30 indexed citations
16.
Baudon, D, et al.. (1997). [Malaria epidemic during a military-humanitarian mission in Africa].. PubMed. 57(3). 253–5. 3 indexed citations
17.
Keundjian, A, et al.. (1996). Electrocardiographic Changes and Halofantrine Plasma Level During Acute Falciparum Malaria. American Journal of Tropical Medicine and Hygiene. 54(3). 225–228. 56 indexed citations
18.
Keundjian, A, et al.. (1995). Human pharmacokinetics of chloroquine and proguanil delivered in a single capsule for malaria chemoprophylaxis.. PubMed. 46(3). 158–60. 5 indexed citations
19.
Partovian, Chohreh, Évelyne Jacqz-Aigrain, A Keundjian, Patrice Jaillon, & Christian Funck‐Brentano. (1995). Comparison of chloroguanide and mephenytoin for the in vivo assessment of genetically determined CYP2C19 activity in humans*. Clinical Pharmacology & Therapeutics. 58(3). 257–263. 15 indexed citations
20.
Funck‐Brentano, Christian, et al.. (1992). Relation between chloroguanide bioactivation to cycloguanil and the genetically determined metabolism of mephenytoin in humans. Clinical Pharmacology & Therapeutics. 51(5). 507–512. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francis Hombhanje Breakdown of academic impact, for papers by WM Watkins Breakdown of academic impact, for papers by K Chalermrut Breakdown of academic impact, for papers by D Bunnag Breakdown of academic impact, for papers by A. M. J. Oduola Breakdown of academic impact, for papers by TE Taylor Breakdown of academic impact, for papers by J Lebras Breakdown of academic impact, for papers by Akintunde Sowunmi Breakdown of academic impact, for papers by Dorina Bustos Breakdown of academic impact, for papers by A. A. Adedeji
Rankless by CCL
2026